You can always count on the CDC to bring the Valentine’s day buzzkill. A new report released by the organization yesterday sheds light on some troubling findings about STD rates in the U.S. Among those: Last year, there were 20 million new cases of sexually transmitted infections, and 110 million total infections. Those numbers are frightening enough on their own, but the news gets even gloomier when you reach the report titled, “CDC Grand Rounds: The Growing Threat of Multidrug-Resistant Gonorrhea.”
In short: The drugs used to treat Gonorrhea—first, penicillin, then a series of stronger antibiotics—aren’t working anymore. Gonorrhea, in other words, is growing stronger and more resistant to treatment faster than we can manufacture drugs to fight it. According to the National Monitor:
Researchers believe that cephalsporins, the current form antibiotics used to treat gonorrhea, are becoming less effective at treating the STD. New antimicrobial treatment options are needed as soon as possible, according to the CDC’s Morbidity and Mortality Weekly Report. However, only one new antimicrobial is undergoing clinical study as a potential treatment for gonorrhea.
“The continued threat of multidrug-resistant gonorrhea makes protecting against [gonorrhea] more important than before,” Dr. Lindsey Satterwhite, an epidemiologist in the CDC’s Division of STD Prevention, told ABC News.
Gone untreated, gonorrhea can cause a wide range of alarming symptoms—infertility, urethra infections, and increased risk of HIV, as MH News reported back in June in The New Super-STD You Must Avoid. As always, your best bet to stay safe: wrap it up. Start with one of the Four Best Rubbers for Men.